Figure 6.
There was no significant difference in cumulative survival rate between the groups, with a median survival time of 121 d in the tolvaptan group and 123 d in the control group.
There was no significant difference in cumulative survival rate between the groups, with a median survival time of 121 d in the tolvaptan group and 123 d in the control group.